Oct 11 (Reuters) - Aptahem AB  APTA.TE :
    * APTAHEM ANNOUNCES STRENGTHENED RESEARCH RESULTS WITH
APTA-1 FROM
COMPLETED NHP STUDY
    * NEW PRECLINICAL RESULTS CONTINUE TO SUPPORT APTA-1'S
MULTIFUNCTIONAL DRUG CANDIDATE POTENTIAL WITHIN TREATMENT OF
SEPSIS
    * NHP STUDY HAS SHOWN THAT APTA-1 HAS ABILITY TO BOTH
DIRECTLY AND
INDIRECTLY AFFECT MECHANISMS THAT LEAD TO A POSITIVE CHANGE IN
HEALTH FOR APTA-1-TREATED ANIMALS THROUGH NOW FURTHER CLARIFIED
MECHANISMS OF ACTION
    * AN ADDITIONAL DISCOVERY FROM NHP STUDY IS APTA-1'S ABILITY
TO
STIMULATE INCREASED PRODUCTION OF PROTEIN THAT HELPS BODY TO
CLEAR DAMAGED OR DEAD CELLS (APOPTOSIS)
    * ADDITIONAL DISCOVERY INDICATES PRELIMINARY THAT APTA-1 MAY
PLAY
AN IMPORTANT ROLE AS PROTECTION AGAINST AUTOIMMUNE DISEASES
    * COMPANY WILL IN COMING FUTURE INVESTIGATE ADDITIONAL
PATENT
OPPORTUNITIES BASED ON THESE NEW RESEARCH RESULTS

Source text for Eikon:  ID:nWkr6X6Zgp 
Further company coverage:  APTA.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))